psalexa

Blockchain in Healthcare Market by Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing Management, Drug Supply Chain Management, Drug Discovery & Clinical Trials, Prescription Drug Abuse) by End User (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Sweden, Estonia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

  • Published: December 2018
  • Report Code: LS11598
  • Available Format: PDF
  • Pages: 141

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Application

1.3.2 Market Segmentation by End User

1.3.3 Market Segmentation by Geography

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Technology Insights

4.1 Structure of Blockchain

4.2 Types of Blockchain

4.2.1 Public Blockchain

4.2.2 Private Blockchain

4.2.3 Consortium Blockchain (Permissioned Blockchain)

4.3 Patent Analysis

4.4 Healthcare Blockchain Consortium

4.4.1 Hashed Health Blockchain Consortium

4.4.2 Humana, MultiPlan, Optum, Quest Diagnostics, and UnitedHealthcare Consortium

4.4.3 The MediLedger Project

4.4.4 The HyperLedger Healthcare Working Group (HLHC Working Group)

4.4.5 My Health My Data (MHMD)

4.4.6 Enterprise Ethereum Alliance (EEA)

4.4.7 Others

Chapter 5. Investment and Funding Scenario

Chapter 6. Introduction

6.1 Definition of Market Segments

6.1.1 By Application

6.1.1.1 Clinical data exchange and interoperability

6.1.1.2 Claims adjudication and billing management

6.1.1.3 Drug supply chain management

6.1.1.4 Drug discovery and clinical trials

6.1.1.5 Prescription drug abuse

6.1.1.6 Others

6.1.2 By End User

6.1.2.1 Pharmaceutical companies

6.1.2.2 Healthcare providers

6.1.2.3 Healthcare payers

6.1.2.4 Others

6.2 Market Dynamics

6.2.1 Trends

6.2.1.1 Increasing number of partnerships and collaborations

6.2.2 Drivers

6.2.2.1 Increasing number of regulations for safeguarding consumer data

6.2.2.2 Growing funding and investments in the blockchain technology

6.2.2.3 Implementation of blockchain in pharmaceutical supply chain

6.2.2.4 Impact analysis of drivers on market forecast

6.2.3 Restraints

6.2.3.1 Lack of awareness about blockchain technology

6.2.3.2 Implementation related challenges

6.2.3.3 Establishing a clear return on investment (ROI) from blockchain technology

6.2.3.4 Regulatory hurdles

6.2.3.5 Impact analysis of restraints on market forecast

6.2.4 Opportunities

6.2.4.1 Need for better management of medical data

6.2.4.2 Increasing incidence of healthcare data breaches and growing threat of substandard counterfeit drugs

6.3 Porter’s Five Forces Analysis

Chapter 7. Global Market Size and Forecast

7.1 By Application

7.2 By End User

7.3 By Region

Chapter 8. North America Market Size and Forecast

8.1 By Application

8.2 By End User

8.3 By Country

Chapter 9. Europe Market Size and Forecast

9.1 By Application

9.2 By End User

9.3 By Country

Chapter 10. APAC Market Size and Forecast

10.1 By Application

10.2 By End User

10.3 By Country

Chapter 11. LATAM Market Size and Forecast

11.1 By Application

11.2 By End User

11.3 By Country

Chapter 12. MEA Market Size and Forecast

12.1 By Application

12.2 By End User

12.3 By Country

Chapter 13. Strategic Developments

13.1 Mergers and Acquisitions

13.2 Product Launches

13.3 Partnerships, Agreements and Collaborations

13.4 Geographic Expansions

13.5 Other Developments

Chapter 14. Company Profiles

14.1 Key Players

14.1.1 International Business Machines Corporation

14.1.1.1 Business overview

14.1.1.2 Product and service offerings

14.1.1.3 Key financial summary

14.1.2 Microsoft Corporation

14.1.2.1 Business overview

14.1.2.2 Product and service offerings

14.1.2.3 Key financial summary

14.1.2.4 Strategic growth plans

14.1.3 Guardtime AS

14.1.3.1 Business overview

14.1.3.2 Product and service offerings

14.1.4 PokitDok Inc.

14.1.4.1 Business overview

14.1.4.2 Product and service offerings

14.1.5 Hashed Health

14.1.5.1 Business overview

14.1.5.2 Product and service offerings

14.1.6 iSolve LLC

14.1.6.1 Business overview

14.1.6.2 Product and service offerings

14.1.7 Patientory Inc.

14.1.7.1 Business overview

14.1.7.2 Product and service offerings

14.1.8 Factom Inc.

14.1.8.1 Business overview

14.1.8.2 Product and service offerings

14.1.9 Chronicled Inc.

14.1.9.1 Business overview

14.1.9.2 Product and service offerings

14.1.10 Accenture PLC

14.1.10.1 Business overview

14.1.10.2 Product and service offerings

14.1.10.3 Key financial summary

14.2 Other Players

14.2.1 Blockverify

14.2.2 FarmaTrust

14.2.3 Blockpharma

14.2.4 DeepMind Technologies Limited

14.2.5 Proof.Works

14.2.6 IRYO.NETWORK

14.2.7 Doc.ai Inc.

14.2.8 Coral Health Research & Discovery Inc.

Chapter 15. Appendix

15.1 Abbreviations

15.2 Sources and References

15.3 Related Reports

List of Table

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 MAJOR BLOCKCHAIN PATENTS APPROVED BY THE USPTO FOR HEALTHCARE APPLICATIONS (2018)

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2017)

TABLE 6 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2018–2023)

TABLE 7 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2017)

TABLE 8 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2018–2023)

TABLE 9 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY REGION, $THOUSAND (2013–2017)

TABLE 10 GLOBAL BLOCKCHAIN IN HEALTHCARE MAREKT, BY REGION, $THOUSAND (2018–2023)

TABLE 11 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2017)

TABLE 12 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2018–2023)

TABLE 13 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2017)

TABLE 14 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2018–2023)

TABLE 15 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2017)

TABLE 16 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2018–2023)

TABLE 17 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2017)

TABLE 18 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2018–2023)

TABLE 19 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2017)

TABLE 20 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2018–2023)

TABLE 21 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2017)

TABLE 22 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2018–2023)

TABLE 23 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2017)

TABLE 24 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2018–2023)

TABLE 25 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2017)

TABLE 26 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2018–2023)

TABLE 27 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2017)

TABLE 28 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2018–2023)

TABLE 29 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2017)

TABLE 30 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2018–2023)

TABLE 31 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2017)

TABLE 32 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2018–2023)

TABLE 33 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2017)

TABLE 34 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2018–2023)

TABLE 35 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2017)

TABLE 36 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2018–2023)

TABLE 37 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2017)

TABLE 38 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2018–2023)

TABLE 39 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2017)

TABLE 40 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2018–2023)

TABLE 41 INTERNATIONAL BUSINESS MACHINES CORPORATION – AT A GLANCE

TABLE 42 INTERNATIONAL BUSINESS MACHINES CORPORATION – KEY FINANCIAL SUMMARY

TABLE 43 MICROSOFT CORPORATION – AT A GLANCE

TABLE 44 MICROSOFT CORPORATION – KEY FINANCIAL SUMMARY

TABLE 45 GUARDTIME AS – AT A GLANCE

TABLE 46 POKITDOK INC. – AT A GLANCE

TABLE 47 HASHED HEALTH – AT A GLANCE

TABLE 48 ISOLVE LLC – AT A GLANCE

TABLE 49 PATIENTORY INC. – AT A GLANCE

TABLE 50 FACTOM INC. – AT A GLANCE

TABLE 51 CHRONICLED INC. – AT A GLANCE

TABLE 52 ACCENTURE PLC – AT A GLANCE

TABLE 53 ACCENTURE PLC – KEY FINANCIAL SUMMARY

TABLE 54 BLOCKVERIFY – AT A GLANCE

TABLE 55 FARMATRUST – AT A GLANCE

TABLE 56 BLOCKPHARMA – AT A GLANCE

TABLE 57 DEEPMIND TECHNOLOGIES LIMITED – AT A GLANCE

TABLE 58 PROOF.WORKS – AT A GLANCE

TABLE 59 IRYO.NETWORK – AT A GLANCE

TABLE 60 DOC.AI INC. – AT A GLANCE

TABLE 61 CORAL HEALTH RESEARCH & DISCOVERY INC. – AT A GLANCE

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 INTENSITY OF RIVALRY

FIG 12 THREAT OF NEW ENTRANTS

FIG 13 THREAT OF SUBSTITUTES

FIG 14 SNAPSHOT OF GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, CAGR (2018–2023)

FIG 15 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2023)

FIG 16 GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2023)

FIG 17 WORLDWIDE MAJOR MARKETS FOR BLOCKCHAIN IN HEALTHCARE

FIG 18 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET SNAPSHOT

FIG 19 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2023)

FIG 20 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2023)

FIG 21 NORTH AMERICA BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2023)

FIG 22 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET SNAPSHOT

FIG 23 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2023)

FIG 24 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2023)

FIG 25 EUROPE BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2023)

FIG 26 APAC BLOCKCHAIN IN HEALTHCARE MARKET SNAPSHOT

FIG 27 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2023)

FIG 28 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2023)

FIG 29 APAC BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2023)

FIG 30 LATAM BLOCKCHAIN IN HEALTHCARE MARKET SNAPSHOT

FIG 31 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2023)

FIG 32 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2023)

FIG 33 LATAM BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2023)

FIG 34 MEA BLOCKCHAIN IN HEALTHCARE MARKET SNAPSHOT

FIG 35 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY APPLICATION, $THOUSAND (2013–2023)

FIG 36 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY END USER, $THOUSAND (2013–2023)

FIG 37 MEA BLOCKCHAIN IN HEALTHCARE MARKET, BY COUNTRY, $THOUSAND (2013–2023)

FIG 38 INTERNATIONAL BUSINESS MACHINES CORPORATION – REVENUE SPLIT BY SEGMENT & GEOGRAPHY (2017)

FIG 39 MICROSOFT CORPORATION – REVENUE SPLIT BY SEGMENT & GEOGRAPHY (2018)

FIG 40 ACCENTURE PLC – REVENUE SPLIT BY SEGMENT AND BY GEOGRAPHY (2018)

Place An Order
USD 4900 USD 5900 USD 7500
Customized Report Solution

Get a bespoke market intelligence solution

 
We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need Us

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws